Vaiet Pharma, S.A. (manufacturing, quality control, primary packaging, batch release for powder)

The drug is indicated for acute and chronic cerebral circulation disorders (due to atherosclerosis, thrombosis, or embolism of the vessels), transient ischemic attacks, headaches, and as adjunctive therapy for arterial hypertension.

Dosage form: lyophilisate for solution for injection

ATC: C04AE02